Arakawa K - Search Results

1

An antidiabetic thiazolidinedione induces eccentric cardiac hypertrophy by cardiac volume overload in rats.

Arakawa K, Ishihara T, Aoto M, Inamasu M, Kitamura K, Saito A. Arakawa K, et al. Clin Exp Pharmacol Physiol. 2004 Jan-Feb;31(1-2):8-13. doi: 10.1111/j.1440-1681.2004.03954.x. Clin Exp Pharmacol Physiol. 2004. PMID: 14756678

2

Long-term treatment with the Na+-glucose cotransporter inhibitor T-1095 causes sustained improvement in hyperglycemia and prevents diabetic neuropathy in Goto-Kakizaki Rats.

Ueta K, Ishihara T, Matsumoto Y, Oku A, Nawano M, Fujita T, Saito A, Arakawa K. Ueta K, et al. Among authors: arakawa k. Life Sci. 2005 Apr 22;76(23):2655-68. doi: 10.1016/j.lfs.2004.09.038. Life Sci. 2005. PMID: 15792833

3

Analysis of the effect of canagliflozin on renal glucose reabsorption and progression of hyperglycemia in zucker diabetic Fatty rats.

Kuriyama C, Xu JZ, Lee SP, Qi J, Kimata H, Kakimoto T, Nakayama K, Watanabe Y, Taniuchi N, Hikida K, Matsushita Y, Arakawa K, Saito A, Ueta K, Shiotani M. Kuriyama C, et al. Among authors: arakawa k. J Pharmacol Exp Ther. 2014 Nov;351(2):423-31. doi: 10.1124/jpet.114.217992. Epub 2014 Sep 12. J Pharmacol Exp Ther. 2014. PMID: 25216746

4

Intestinal Sodium Glucose Cotransporter 1 Inhibition Enhances Glucagon-Like Peptide-1 Secretion in Normal and Diabetic Rodents.

Oguma T, Nakayama K, Kuriyama C, Matsushita Y, Yoshida K, Hikida K, Obokata N, Tsuda-Tsukimoto M, Saito A, Arakawa K, Ueta K, Shiotani M. Oguma T, et al. Among authors: arakawa k. J Pharmacol Exp Ther. 2015 Sep;354(3):279-89. doi: 10.1124/jpet.115.225508. Epub 2015 Jun 23. J Pharmacol Exp Ther. 2015. PMID: 26105952

5

Reduction of renal transport maximum for glucose by inhibition of NA(+)-glucose cotransporter suppresses blood glucose elevation in dogs.

Ueta K, Yoneda H, Oku A, Nishiyama S, Saito A, Arakawa K. Ueta K, et al. Among authors: arakawa k. Biol Pharm Bull. 2006 Jan;29(1):114-8. doi: 10.1248/bpb.29.114. Biol Pharm Bull. 2006. PMID: 16394522 Free article.

6

The effect of combined treatment with canagliflozin and teneligliptin on glucose intolerance in Zucker diabetic fatty rats.

Oguma T, Kuriyama C, Nakayama K, Matsushita Y, Yoshida K, Kiuchi S, Ikenaga Y, Nakamaru Y, Hikida K, Saito A, Arakawa K, Oka K, Ueta K, Shiotani M. Oguma T, et al. Among authors: arakawa k. J Pharmacol Sci. 2015 Apr;127(4):456-61. doi: 10.1016/j.jphs.2015.03.006. Epub 2015 Mar 28. J Pharmacol Sci. 2015. PMID: 25892328 Free article.

7

Changes in glucose-induced plasma active glucagon-like peptide-1 levels by co-administration of sodium-glucose cotransporter inhibitors with dipeptidyl peptidase-4 inhibitors in rodents.

Oguma T, Kuriyama C, Nakayama K, Matsushita Y, Hikida K, Tsuda-Tsukimoto M, Saito A, Arakawa K, Ueta K, Minami M, Shiotani M. Oguma T, et al. Among authors: arakawa k. J Pharmacol Sci. 2016 Dec;132(4):255-261. doi: 10.1016/j.jphs.2016.10.006. Epub 2016 Oct 28. J Pharmacol Sci. 2016. PMID: 27889414 Free article.

8

Beneficial effects of canagliflozin in combination with pioglitazone on insulin sensitivity in rodent models of obese type 2 diabetes.

Watanabe Y, Nakayama K, Taniuchi N, Horai Y, Kuriyama C, Ueta K, Arakawa K, Senbonmatsu T, Shiotani M. Watanabe Y, et al. Among authors: arakawa k. PLoS One. 2015 Jan 23;10(1):e0116851. doi: 10.1371/journal.pone.0116851. eCollection 2015. PLoS One. 2015. PMID: 25615826 Free PMC article.

9

Involvement of heparan sulfate in the renoprotective effects of imidapril, an angiotensin-converting enzyme inhibitor, in diabetic db/db mice.

Yoneda H, Ueta K, Nagasaki M, Arakawa K. Yoneda H, et al. Among authors: arakawa k. J Recept Signal Transduct Res. 2014 Feb;34(1):21-5. doi: 10.3109/10799893.2013.845788. Epub 2013 Oct 4. J Recept Signal Transduct Res. 2014. PMID: 24094140

10

Canagliflozin, a sodium glucose cotransporter 2 inhibitor, attenuates obesity-induced inflammation in the nodose ganglion, hypothalamus, and skeletal muscle of mice.

Naznin F, Sakoda H, Okada T, Tsubouchi H, Waise TM, Arakawa K, Nakazato M. Naznin F, et al. Among authors: arakawa k. Eur J Pharmacol. 2017 Jan 5;794:37-44. doi: 10.1016/j.ejphar.2016.11.028. Epub 2016 Nov 19. Eur J Pharmacol. 2017. PMID: 27876617

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,345 results

Search Page